Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 59

2.

Synaptic plasticity and addiction: learning mechanisms gone awry.

Mameli M, Lüscher C.

Neuropharmacology. 2011 Dec;61(7):1052-9. doi: 10.1016/j.neuropharm.2011.01.036. Epub 2011 Jan 28. Review.

PMID:
21277315
4.

Synaptic plasticity and drug addiction.

Jones S, Bonci A.

Curr Opin Pharmacol. 2005 Feb;5(1):20-5. Review.

PMID:
15661621
5.

Relapse to drug-seeking: neural and molecular mechanisms.

Self DW, Nestler EJ.

Drug Alcohol Depend. 1998 Jun-Jul;51(1-2):49-60. Review.

PMID:
9716929
6.

Insights to drug addiction derived from ultrastructural views of the mesocorticolimbic system.

Morales M, Pickel VM.

Ann N Y Acad Sci. 2012 Feb;1248:71-88. doi: 10.1111/j.1749-6632.2011.06299.x. Epub 2011 Dec 16. Review.

PMID:
22171551
7.

Hypocretin modulation of drug-induced synaptic plasticity.

Baimel C, Borgland SL.

Prog Brain Res. 2012;198:123-31. doi: 10.1016/B978-0-444-59489-1.00008-2. Review.

PMID:
22813972
8.

Role of orexin/hypocretin and CRF in the formation of drug-dependent synaptic plasticity in the mesolimbic system.

Bonci A, Borgland S.

Neuropharmacology. 2009;56 Suppl 1:107-11. doi: 10.1016/j.neuropharm.2008.07.024. Epub 2008 Jul 24. Review.

PMID:
18694770
9.

Synaptic plasticity in drug reward circuitry.

Winder DG, Egli RE, Schramm NL, Matthews RT.

Curr Mol Med. 2002 Nov;2(7):667-76. Review.

PMID:
12420805
10.

Opiates and plasticity.

Dacher M, Nugent FS.

Neuropharmacology. 2011 Dec;61(7):1088-96. doi: 10.1016/j.neuropharm.2011.01.028. Epub 2011 Jan 25. Review.

PMID:
21272593
11.

Optogenetic interrogations of the neural circuits underlying addiction.

Britt JP, Bonci A.

Curr Opin Neurobiol. 2013 Aug;23(4):539-45. doi: 10.1016/j.conb.2013.01.010. Epub 2013 Jan 31. Review.

12.

Structural plasticity associated with exposure to drugs of abuse.

Robinson TE, Kolb B.

Neuropharmacology. 2004;47 Suppl 1:33-46. Review.

PMID:
15464124
13.

Elevated levels of GluR1 in the midbrain: a trigger for sensitization to drugs of abuse?

Carlezon WA Jr, Nestler EJ.

Trends Neurosci. 2002 Dec;25(12):610-5. Review.

PMID:
12446127
14.

Mechanisms of Action and Persistent Neuroplasticity by Drugs of Abuse.

Korpi ER, den Hollander B, Farooq U, Vashchinkina E, Rajkumar R, Nutt DJ, Hyytiä P, Dawe GS.

Pharmacol Rev. 2015 Oct;67(4):872-1004. doi: 10.1124/pr.115.010967. Review.

15.

It could be habit forming: drugs of abuse and striatal synaptic plasticity.

Gerdeman GL, Partridge JG, Lupica CR, Lovinger DM.

Trends Neurosci. 2003 Apr;26(4):184-92. Review.

PMID:
12689769
16.

Stress and VTA synapses: implications for addiction and depression.

Polter AM, Kauer JA.

Eur J Neurosci. 2014 Apr;39(7):1179-88. doi: 10.1111/ejn.12490. Review.

17.

Human brain plasticity: evidence from sensory deprivation and altered language experience.

Neville H, Bavelier D.

Prog Brain Res. 2002;138:177-88. Review.

PMID:
12432770
18.

Drug-evoked synaptic plasticity: beyond metaplasticity.

Creed MC, Lüscher C.

Curr Opin Neurobiol. 2013 Aug;23(4):553-8. doi: 10.1016/j.conb.2013.03.005. Epub 2013 Apr 6. Review.

PMID:
23571119
19.

Integrating synaptic plasticity and striatal circuit function in addiction.

Grueter BA, Rothwell PE, Malenka RC.

Curr Opin Neurobiol. 2012 Jun;22(3):545-51. doi: 10.1016/j.conb.2011.09.009. Epub 2011 Oct 12. Review.

20.

Modulation of cellular activity and synaptic transmission in the ventral tegmental area.

Mathon DS, Kamal A, Smidt MP, Ramakers GM.

Eur J Pharmacol. 2003 Nov 7;480(1-3):97-115. Review.

PMID:
14623354

Supplemental Content

Support Center